Abstract
Background: Due to its nutritional and medicinal values, the leaf of Telfairia occidentalis Hook f. (Cucurbitaceae) is consumed in different parts of Nigeria. Acute and sub-chronic toxicity of the hydroethanolic leaf extract of Telfairia occidentalis were investigated in this study. Methods: Sixty-four male rats were randomized into four different groups of 16 animals each and were separately administered 80, 400 and 2000 mg/kg T. occidentalis orally (p.o.) for 60 days. Animals were sacrificed and blood samples were collected for hematological and biochemical analyses. Vital organs were harvested and evaluated for in vivo antioxidants and histopathological changes. Results: A significant (p < 0.05) reduction in weight of the testes, compared to the control group, was observed in the group treated with 2000 mg/kg extract. No significant change was observed in the weight of other vital organs relative to the control group. There were significant (p < 0.01) increases in sperm motility and count in the group administered 80 mg/kg extract and significant (p < 0.001) reductions in both parameters at 2000 mg/kg. There were significant increases in the levels of hemoglobin and packed cell volume at 80 and 2000 mg/kg of the extract. In respect of liver function parameters, significant reductions in aspartate aminotransferase and alanine aminotransferase levels at doses of 400 and 2000 mg/kg relative to control were observed. Compared to control, the extract significantly reduced (p < 0.05) the level of total cholesterol (400 mg/kg) and caused a significant increase in the level of high-density lipoprotein (80, 400 and 2000 mg/kg). Significant (p < 0.05) increase in the level of malondialdehyde, decrease in superoxide dismutase level and histopathological abnormalities were observed in the testes at 2000 mg/kg. Upon cessation of treatment with T. occidentalis for 30 days, the observed effects were reversed. Conclusions: The findings showed that the hydroethanolic leaf extract of Telfairia occidentalis is relatively non-toxic on acute and sub-chronic exposures at low to moderate doses, with the potential to elicit anti-anemic effects, reduce the risk of atherosclerosis and cardiovascular disease, and enhance antioxidant status in the brain and liver. Although possibly beneficial at low to moderate doses, the extract could be harmful to the testes with prolonged oral exposure at high dose.
Highlights
People of diverse social classes worldwide increasingly use herbal remedies, with phytotherapy being a major form of treatment for more than 70% of the world’s population.Medicines 2018, 5, 4; doi:10.3390/medicines5010004 www.mdpi.com/journal/medicinesHerbal preparations currently serve the health needs of many populations and there is clear evidence of their therapeutic benefits [1]
Fresh leaves of T. occidentalis were obtained from a local herb market in Mushin, Lagos State, Nigeria
The results of the preliminary phytochemical screening showed the presence of oils, saponins, phlobatannins and tannins in the T. occidentalis hydroethanolic leaves extract
Summary
People of diverse social classes worldwide increasingly use herbal remedies, with phytotherapy being a major form of treatment for more than 70% of the world’s population.Medicines 2018, 5, 4; doi:10.3390/medicines5010004 www.mdpi.com/journal/medicinesHerbal preparations currently serve the health needs of many populations and there is clear evidence of their therapeutic benefits [1]. Despite the belief and claim of being natural and safe, herbal remedies have been associated with lethal effects, which have been attributed to several factors. These factors include hepatic toxicity of the main constituents and contamination of preparations by heavy metals or microorganisms [2]. Due to its nutritional and medicinal values, the leaf of Telfairia occidentalis. Acute and sub-chronic toxicity of the hydroethanolic leaf extract of Telfairia occidentalis were investigated in this study. Methods: Sixty-four male rats were randomized into four different groups of 16 animals each and were separately administered 80, 400 and 2000 mg/kg T. occidentalis orally (p.o.) for 60 days.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.